ONCAlert | Upfront Therapy for mRCC
Bladder Cancer: Articles
Unique Immunotherapy Combinations Provide an Optimistic Outlook in Early Urothelial Carcinoma Trials
2:26 PM, Mon March 11, 2019
Encouraging Early Findings Seen With Sacituzumab Govitecan in Urothelial Carcinoma
3:12 PM, Tue March 5, 2019
Pembrolizumab/Lenvatinib Combo Shows Activity in Small Urothelial Cancer Study
4:41 PM, Mon March 4, 2019
Expert Highlights Encouraging Findings With Bempegaldesleukin and Nivolumab in Metastatic Urothelial Carcinoma
10:28 PM, Mon February 18, 2019
Activity Seen With Sacituzumab Govitecan in Advanced Urothelial Carcinoma
6:43 PM, Mon February 18, 2019
Grivas Highlights Advances in Bladder Cancer
6:07 PM, Mon February 11, 2019
Expert Shares Treatment Options for Localized Muscle-Invasive Bladder Cancer
4:42 PM, Mon February 11, 2019
Neoadjuvant Dose-Dense MVAC Demonstrates Superior Survival Outcomes in Bladder Cancer
7:39 PM, Fri January 11, 2019
